Clinical Trials Logo
  1. Home
  2. Prolactinoma
  3. NCT03353025

Study on Therapy of Non-invasive Prolactinoma — TNAPA  

Prolactinoma Clinical Trial

Official title:
Prospective Randomized Clinical Study on Transsphenoidal or Dopamine Drugs Therapy Treat Non-invasive Prolactinoma

Clinical Trial Summary

the study aim to investigate the endocrine remission rate of non-invasive prolactinoma between transsphenoidal surgery treatment and Dopamine agonist treatment.

Clinical Trial Description

Non-invasive prolactinomas were treated by transsphenoidal surgery or Dopamine agonist until now. However，this two type therapies were controversial. The study aim to investigate the endocrine remission rate of non-invasive prolactinoma between transsphenoidal surgery treatment and Dopamine agonist treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03353025
Study type Interventional
Source First Affiliated Hospital, Sun Yat-Sen University
Contact Zongming Wang, Dr.
Phone 8613570903721
Email wzmyan@foxmail.com
Status Recruiting
Phase N/A
Start date January 1, 2016
Completion date December 31, 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT03038308 - Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole Phase 1/Phase 2
Not yet recruiting NCT03400865 - Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas N/A
Completed NCT00481299 - Insulin Resistance in Women With Prolactinoma N/A
Terminated NCT04106531 - Validation of a Quality of Life Metric "Prolac-10"
Completed NCT01504399 - Rhinological Outcomes in Endonasal Pituitary Surgery
Recruiting NCT03474601 - Seoul National University Pituitary Disease Cohort Study
Recruiting NCT04107480 - PRolaCT - Three Prolactinoma RCTs Phase 4
Completed NCT00697814 - Clomiphene in Males With Prolactinomas and Persistent Hypogonadism Phase 2
Completed NCT05236829 - Exercise Capacity and Physical Activity Level in Prolactinoma Patients
Recruiting NCT03457389 - Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma N/A
Recruiting NCT01775332 - Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools N/A
Not yet recruiting NCT03717454 - Dopamine D2 Receptors(D2R) Imaging in Prolactinomas N/A
Recruiting NCT00001595 - An Investigation of Pituitary Tumors and Related Hypothalmic Disorders